Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Meissner

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The American Journal of Physiology|November 1, 1978
Insulin release, cGMP, cAMP, and membrane potential in acetylcholine-stimulated isletsE Gagerman, L A Idahl, H P Meissner, et al.
Diabetologia|September 1, 1985
Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamideM G Garrino, W Schmeer, M Nenquin, et al.
Biochemical Pharmacology|July 1, 1985
Sparteine increases insulin release by decreasing the K+ permeability of the B-cell membraneG Paolisso, M Nenquin, W Schmeer, et al.
Diabetologia|December 1, 1995
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)D Ziegler, M Hanefeld, K J Ruhnau, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 10, 2000
Acquired generalized lipoatrophy (AGL): highly selective MR lipid imaging and localized (1)H-MRSK Brechtel, S Jacob, J Machann, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 3, 2000
Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathyK J Ruhnau, H P Meissner, J R Finn, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The American Journal of Physiology|November 1, 1978
Insulin release, cGMP, cAMP, and membrane potential in acetylcholine-stimulated isletsE Gagerman, L A Idahl, H P Meissner, et al.
Diabetologia|September 1, 1985
Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamideM G Garrino, W Schmeer, M Nenquin, et al.
Biochemical Pharmacology|July 1, 1985
Sparteine increases insulin release by decreasing the K+ permeability of the B-cell membraneG Paolisso, M Nenquin, W Schmeer, et al.
Diabetologia|December 1, 1995
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)D Ziegler, M Hanefeld, K J Ruhnau, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 10, 2000
Acquired generalized lipoatrophy (AGL): highly selective MR lipid imaging and localized (1)H-MRSK Brechtel, S Jacob, J Machann, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 3, 2000
Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathyK J Ruhnau, H P Meissner, J R Finn, et al.
Pageof 3